Cargando…
Altered GABA(A) receptor density and unaltered blood–brain barrier [(11)C]flumazenil transport in drug-resistant epilepsy patients with mesial temporal sclerosis
Studies in rodents suggest that flumazenil is a P-glycoprotein substrate at the blood–brain barrier. This study aimed to assess whether [(11)C]flumazenil is a P-glycoprotein substrate in humans and to what extent increased P-glycoprotein function in epilepsy may confound interpretation of clinical [...
Autores principales: | Froklage, Femke E, Postnov, Andrey, Yaqub, Maqsood M, Bakker, Esther, Boellaard, Ronald, Hendrikse, N Harry, Comans, Emile FI, Schuit, Robert C, Schober, Patrick, Velis, Demetrios N, Zwemmer, Jack, Heimans, Jan J, Lammertsma, Adriaan A, Voskuyl, Rob A, Reijneveld, Jaap C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167109/ https://www.ncbi.nlm.nih.gov/pubmed/26661244 http://dx.doi.org/10.1177/0271678X15618219 |
Ejemplares similares
-
[(11)C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoprotein
por: Froklage, Femke E, et al.
Publicado: (2012) -
Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology
por: Cheebsumon, Patsuree, et al.
Publicado: (2012) -
Effects of erlotinib therapy on [(11)C]erlotinib uptake in EGFR mutated, advanced NSCLC
por: Bahce, Idris, et al.
Publicado: (2016) -
Pharmacokinetic modeling of [(11)C]flumazenil kinetics in the rat brain
por: Lopes Alves, Isadora, et al.
Publicado: (2017) -
Flumazenil-induced ballism.
por: Kim, Joong-Seok, et al.
Publicado: (2003)